Huawei Unveils the AI WAN Solution, Accelerating Transition to the Net5.5G Intelligent Network Era
BARCELONA, Spain, March 4, 2025 /PRNewswire/ -- At MWC Barcelona 2025, Leon Wang, President of Huawei's Data Communication Product Line, unveiled the AI WAN Solution during the product and solution launch event. He noted that carriers are...
"Sanpoku Bio-Regional Park" to Launch in May in Northeastern Japan
MURAKAMI, Japan, March 4, 2025 /PRNewswire/ -- The Sanpoku Revitalization Council will launch in May the "Sanpoku Bio-Regional Park" in the Sanpoku area of Murakami City, Niigata Prefecture, northeastern Japan. The park offers visitors the...
MVGX and World Free Zones Organization Partner to Advance Sustainability in Free Zones Worldwide
SINGAPORE, March 4, 2025 /PRNewswire/ -- MVGX Tech Pte Ltd (MVGX), a subsidiary of Alpha Ladder Group and a leader in sustainability solutions, and the World Free Zones Organization (WFZO), the global body representing 1,600 free zones and...
FiberHome Shines at MWC 2025: Pioneering a Bright Digital Future
BARCELONA, Spain, March 4, 2025 /PRNewswire/ -- The global spotlight turned to the 2025 World Mobile Communications Congress (MWC), where FiberHome made a dazzling appearance under the theme "Connecting the Bright Digital Future." Showcasing...
Ribbon Expands Portfolio of Innovative, Cost Efficient Routers
NPT 2714 and NPT 2705 deliver increased network flexibility and investment protection TOKYO, March 4, 2025 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a prominent supplier of real-time communications technology and IP optical...
Digital Domain and TOPPAN Holdings Launch Collaboration on Virtual Human Solutions
Utilizing biometric data from real-world people to create high-quality virtual humans that can be provided for diverse services HONG KONG, March 4, 2025 /PRNewswire/ -- Digital Domain Content (Hong Kong) Limited ("Digital Domain"), a wholly-owned...
Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®
STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1], [2] The FDA approval is based on robust clinical evidence, which show...
Chulalongkorn University Unveils Exoskeleton Wheelchair to Aid Mobility
BANGKOK, March 4, 2025 /PRNewswire/ -- Chulalongkorn University has introduced the Exoskeleton Wheelchair, an innovative robotic suit designed to help people with disabilities stand, walk, and move more independently. The breakthrough was developed...